Polymicrobial nature of tick-borne diseases 430 of 678 (63%) positive for at least one human pathogen 57% Adults/27% Nymphs – Lyme 14% Adults/15% Nymphs -Babesia 14% Adults/2% Nymphs –...
Out of 1770 children evaluated in the emergency department for Lyme disease, 362 (20.5%) were diagnosed with the condition. Among those with a documented tick bite history, only a small percentage (18.5%, 95% confidence interval 14.6-23.0%) of Lyme disease cases were associated with a recognized tick bite. Therefore, the absence of a tick bite history does not reliably rule out Lyme disease.
Melanie Uhde, Alyssa Indart, Brian A Fallon, Gary P Wormser, Adriana R Marques, Suzanne D Vernon, Armin Alaedini, C-Reactive Protein Response in Patients With Post-Treatment Lyme Disease Symptoms Versus Those With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Clinical Infectious Diseases, Volume 67, Issue 8, 15 October 2018, Pages 1309–1310, https://doi.org/10.1093/cid/ciy299
The data suggest the presence of different inflammatory mechanisms in ME/CFS compared to PTLDS. This difference may stem from the potentially more diverse causes of ME/CFS symptoms compared to PTLDS. The lack of a significantly elevated CRP response in ME/CFS, despite indications of activation in other inflammatory pathways, requires further investigation.
li Divan, Timothy Casselli, S. Anand Narayanan, Sanjib Mukherjee, David C. Zawieja, John A. Watt, Catherine A. Brissette, M. Karen Newell-Rogers, Published: May 3, 2018. https://doi.org/10.1371/journal.pone.0196893
Traditionally, mice haven’t shown neuroborreliosis, mirroring human symptoms, but this study achieved colonization of the central nervous system in mice. Using two strains of B. burgdorferi, researchers infected mice through the skin, consistently detecting spirochetes in the brain membranes 75 days post-infection. Live spirochetes were present, adhering to blood vessels, indicating long-term infection. The presence of CD3+ T cells suggested an immune response. These findings provide new avenues for studying neuroborreliosis and may offer insights into potential treatments for patients.
Presented by Southern Tier Lyme Support, Inc - Kenneth A. Bock, M.D., FAAFP, FAAFP, CNS, received his MD with Honor from the University of Rochester School of Medicine in 1979, and is the founder of...
The immune response to invasive microbes involves two main components: the innate and adaptive response. C-reactive protein (CRP) and serum amyloid A (SAA) are proteins elevated during inflammation. In Lyme disease, CRP is elevated in early stages with erythema migrans but normal in neurological symptoms and arthritis. However, post-treatment Lyme disease syndrome (PTLDS) shows higher CRP, indicating persistent inflammation. SAA is elevated only in patients with erythema migrans. These findings suggest that lingering symptoms post-antibiotic therapy in Lyme disease are associated with elevated CRP, warranting further study on long-term inflammatory processes.
Dr. Moorcroft discusses an Osteopathic approach to Lyme Disease & Tick-borne Co-infections at the 2016 Lyme Conference at Binghamton University, Co-hosted by Southern Tier Lyme Support, Inc....
A fantastic overview of Lyme disease. This presentation covers Lyme as it exists, and how it can effect those with a PANS/PANDAS...
When Your Child Has Lyme Disease: A Parent's Survival Guide is filled with information parents need to know about Lyme, as well as practical strategies based on the authors' personal and professional...
Dr. Fritz will discuss signs and symptoms of PANS/Lyme and appropriate evaluation and treatment, including natural and pharmaceutical antimicrobials, immune modulating therapy, and an integrative...
A significant portion of Lyme disease-treated patients experiences persistent symptoms for months or even years, including pain, fatigue, and neurocognitive issues, collectively referred to as post-treatment Lyme disease syndrome. Determining whether ongoing infection is present remains challenging with current technology, raising an open question. Alternatively, a post-infectious immune-mediated process could be responsible for sustained symptoms.
As fatigue and depression significantly impact the reported decline in both physical and mental functioning in patients with PTLDS, clinicians should thoroughly evaluate these symptoms. It is advisable to consider addressing these issues when selecting treatment interventions. Subsequent controlled studies should investigate the efficacy of such approaches for patients dealing with PTLDS.